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Abstract
Background: To date, few parameters have been found that can aid in patient selection and surgical strategy for eloquent
area gliomas.
Aims: The aim of the study was to analyze preoperative and intraoperative factors that can predict functional outcome and
extent of resection in eloquent area tumors.
Patients and Methods: A retrospective analysis was conducted on 60 patients harboring supratentorial gliomas in eloquent
areas undergoing awake surgery. The analysis considered clinical, neuroradiologic (morphologic), intraoperative, and
postoperative factors. End-points were extent of resection (EOR) as well as functional short- and long-term outcome.
Postoperatively, MRI objectively established the EOR. x2 analyses were used to evaluate parameters that could be predictive.
Multivariate logistic regression analyses were used to evaluate the best combination to predict binary positive outcomes.
Results: In 90% of the cases, subcortical stimulation was positive in the margins of the surgical cavity. Postoperatively, 51%
of the patients deteriorated but 90% of the patients regained their preoperative neurological score. Factors negatively
affecting EOR were volume, degree of subcortical infiltration, and presence of paresis (P,0.01). Sharp margins and cystic
components were more amenable to gross total resection (P,0.01). Contrast enhancement (P,0.02), higher grade
(P,0.01), paresis (P,0.01), and residual tumor in the cortex (P,0.02) negatively affected long-term functional outcomes,
whereas postoperative deterioration could not be predicted for any factor other than paresis. Subcortical stimulation did
not correlate with deterioration, both postoperatively (P,0.08) and at follow-up (P,0.042).
Conclusions: Biological and morphological factors such as type of margins, volume, preoperative neurological status, cystic
components, histology and the type of infiltration into the white matter must be considered when planning intraoperative
mapping.
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Introduction
Supratentorial gliomas are a heterogeneous group of brain
tumors accounting for approximately 30% of all adult primary
intracranial tumors and more than half of these are high-grade
gliomas (HGGs). These lesions are extremely aggressive, and the
vast majority of patients invariably suffer tumor recurrence, with
the median survival time ranging from 1 to 3 years after initial
diagnosis. Despite facing a better prognosis when compared with
higher grade glial tumors, 50–75% of patients harboring low-
grade gliomas eventually die of their disease. Median survival
times have been reported to range between 5 and 10 years, and
estimates of 10-year survival rates range from 5–50% [1–3]. For
high-grade gliomas, the extent of resection (EOR) is a largely
accepted parameter that significantly influence the prognosis both
in terms of overall survival and progression free survival [4–6].
More recently, robust evidence has supported the importance of
gross total resection for the prognosis of low-grade gliomas (LGGs)
[7–11].
Studies that stress the necessity of achieving a wider larger
resection have prompted a discussion regarding the importance of
maintaining an adequate postoperative functional status as a goal
both in LLGs and HGGs, particularly in ‘‘eloquent areas tumors’’
(EATs). In fact, for HGGs, the short life expectancy and the
routine use of adjuvant treatments require a good postoperative
performance status because the time in which recovery can occur
is short and the treatments can potentially exacerbate deteriora-
tion. Some authors [12] have demonstrated that postoperative low
performance status can often impede the administration of
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adjuvant treatments; thus, resulting in decreased survival. Con-
versely, LGG patients survive longer and are younger; therefore, a
permanent deficit will be more difficult to accept because surgery
cannot heal this disease.
The increasing use of preoperative and intraoperative brain
mapping techniques has radically changed the classical concept of
standardized eloquent areas; thus, shifting towards a more
individualized approach. For surgical treatment of both HGG
and LGG, it is largely recognized that preoperative and
intraoperative brain mapping are crucial for maximizing resection
while minimizing morbidity [13–17]. Unfortunately, it is not clear
which pre-, intra-, and postoperative parameters can aid in
preoperatively predicting the EOR or the risk of postoperative
exacerbation; thus, it is difficult to define patient subgroups.
Understandably, the majority of the studies of glioma surgery
outcomes had the goal of assessing prognostic factors related
primarily to survival and/or tumor progression [18–20].
In the current work, we attempted to collect radiological,
clinical, and surgical datasets of patients with gliomas in
intraoperatively confirmed eloquent areas. The goal was to detect
elements that could aid in the prediction of functional outcome
and extent of resection in eloquent area tumors.
Ethics Statement
This retrospective study design was approved by the ethical
committee of our Institution (Spedali Civili di Brescia). The need
for informed consent from participants was waived by the
committee. All patients provided their written and informed
consent for all surgical and therapeutic treatments.
Patients and Methods
This is a retrospective analysis of patients harboring supraten-
torial gliomas located in presumed eloquent areas, operated on via
awake surgery and CSES (cortical and subcortical electrical
stimulation) from October 2009 through May 2012. Clinical,
surgical, and radiological data collection were obtained via the
analysis of inpatient and outpatient charts. Since the study was
aimed at further defining the criteria for selecting patients for
awake surgery and CSES, only patients who underwent a
craniotomy and resection were considered. To increase homoge-
neity, we did not consider surgical resection of tumors that crossed
the midline or had a hemispheric diffusion. Similarly, patients with
any of the following characteristics were not considered to be
surgical candidates: tumors located in the central region overlap-
ping the rolandic fissure; tumors completely invading pre- or post-
central gyri; or tumors invading multiple lobes. In some cases, the
patients had undergone a stereotactic tumor biopsy at another
institutions before undergoing a craniotomy at our facility. Only
patients older than 18 years without any history of previous chemo
or radiotherapy were evaluated. Three outcome measurements
were calculated: extent of resection (EOR), postoperative neuro-
logical status, and neurological status at the six-month follow-up
exam.
Preoperative and Postoperative Clinical and Radiological
Data
All patients were evaluated by expert neurologists or neurosur-
geons; signs and symptoms were collected and classified as:
asymptomatic, seizures, language disturbances, and/or sensory-
motor deficits. To express the preoperative functional status and to
have a baseline score to be compared to the immediate
postoperative and six-month outcome, the Rankin Modified Score
(RMS) and KPS were used. A RMS score was assigned during the
postoperative period (in the first 30 days post-surgery) and at the 6-
month follow-up. Attention was paid to the eventual use of steroids
preoperatively and to the effect of the therapy (improvement of
symptoms vs. no improvement). It should be noted that we
consider improvement after steroid administration as an eventual
proof that there was no direct damage to the eloquent area but
only an effect of the edema. All the patients underwent gadolinium
enhanced MRI, and the T2 FLAIR sequences were specifically
used to clarify the extension of LGG. All the tumors were
considered to be in eloquent areas based on their anatomical
relationships. This means that for language areas, the tumors
infiltrated the cortex and/or the white matter of dominant frontal
and temporal opercula, supramarginal gyrus (SMG), angular gyrus
(AG), middle and inferior parietal gyri (MPG or IPG). For sensory-
motor areas, the tumors were considered eloquent if they either
infiltrated the cortex and/or the white matter of pre- and post-
central gyri or were located in supplementary motor areas (SMA)
or the dorsal and ventral premotor cortex (PMC). Clearly, patients
with tumors located in premotor areas in the dominant
hemisphere also had their language function tested pre- and
intra-operatively. We used fMRI for preoperative planning,
primarily to determine the activation pattern, the location of the
pre- or post-central gyrus, and the approximate distance to the
tumor. If the distance from the activation spot is greater than one
gyrus or the subcortical infiltration is minimal, we may opt to not
perform awake surgery with CSES. For tumors in language areas,
we calculate the lateralization index that, together with neuropsy-
chological testing, provides information concerning the dominant
hemisphere. Since all the tumors were located inside or in close
contact with strongly presumed eloquent areas and the goal of the
study was to detect subgroups of patients at higher risk of
functional worsening, we analyzed the different types of local
infiltration with special attention to growth towards white matter
tracts. The visual anatomical limit on MRI to define the
infiltration of subcortical connections was the end of the sulcus
(Figure 1). The MRI patterns of invasion of the subcortical white
matter were classified into 5 groups: (1) tumors invading and
confined to only 1 gyrus; (2) tumors invading 1 gyrus with
extension to white matter and/or adjacent gyrus; (3) tumors
infiltrating up to 3 gyri and extending toward the long range white
matter tracts; (4) tumors primarily located in the white matter
below eloquent gyri; and (5) lobar tumors. Although this
classification is directly related to the tumor volume, it can add
further information regarding the relationship between the tumor
and the eloquent gyri white matter. Other morphological data
used for the analysis were volume (cm3), gadolinium uptake,
presence of cystic components, margins morphology (sharp or
irregular). Preoperative volumes and residual tumor on postoper-
ative MRI were calculated by manual segmentation of T1 contrast
enhancement or T2 hypersignal. Because some patients under-
went a preoperative MRI at other Institutions, we uploaded the
DICOM datasets on our workstation. For HGGs, the postoper-
ative residual tumor was calculated on the basis of the volume of
contrast enhancement. For LGGs, the evaluation of the EOR was
performed by calculating the volume of the hyperintense signal on
FLAIR sequence (preoperative tumor volume – postoperative
residue volume/preoperative tumor volume).
Consequently, the EOR was classified as gross total resection
(GTR) if the tumor was resected for $95% of volume; subtotal
resection (STR) if the tumor was removed by 85–95%; and partial
resection (PR) if the tumor resection accounted for ,85% [22,23].
Finally, the location of the residual tumor (cortico-subcortical or
only subcortical) was established on the postoperative MRI.
Prognostic Factors in Eloquent Area Gliomas
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Intraoperative Protocol
All patients were operated on with an awake-asleep protocol
after the scalp block was administered and the Mayfield head
clamp was inserted. A detailed description of the mapping
technique can be found in our previous study [17]. Briefly, a
bipolar fork measuring 6 mm in distance between the electrodes,
delivers a non-deleterious, biphasic square-wave current in 4-
second trains at 60 Hz. Stimulation began at 1 mA and increases
by 0.30 mA until generation of contralateral side movement or a
paraesthesia occurred. Every positive site was restimulated to
confirm reproducibility of stimuli. When tumors are located in
language areas, a neuropsychologist administers different tests
(picture identification, reading, counting, and writing) and reports
the type of disturbance observed (speech arrest, anartria, anomia,
reading errors, or acalculia). The patient is unaware of the timing
of stimulation, and the current is delivered just before presentation
of the slide. After identification of a language error, the patient
rests for a short period; then the spontaneous speech and slide
reading are tested, and stimulation starts again. For subcortical
tumors, we test language or motor areas throughout the
subcortical resection, stopping whenever anomalies appear.
Parameters such as current intensity, reproducibility of stimuli,
and seizure occurrence are observed and registered. With the
current study we first reviewed whether the presumed neurora-
diologic eloquence was confirmed during CSES and also if the
cortical or subcortical positive sites were just in contact with or
infiltrated by the tumor (by correlating these sites with the position
of the residual tumor on the postoperative MRI). In order to
determine whether detection of eloquent sites was associated ‘‘per
se’’ with poor functional outcome and restricted resections, these
intraoperative findings were then matched with the EOR and
postoperative RMS in the statistical analysis.
The histopathologic criteria were established according to the
World Health Organization 2007 diagnostic consensus criteria.
Grading of the tumors was reported as WHO II, III, or IV where
the grade II gliomas were also defined as a low-grade glioma,
grade III as an anaplastic glioma, and grade IV as glioblastoma
multiforme (GBM). The WHO grade was considered in the
statistical analysis and matched with the EOR and functional
outcome.
Statistical Analyses
Statistical analyses and descriptive statistics were performed
using SPSS 19.0 statistical software (SPSS, Inc., Chicago, IL). We
created different categorical classes for a number of clinical,
radiological, and intraoperative parameters that could be predic-
tive of postoperative outcome. When there were less than 6 cases
in a category we unified some classes to attain a sufficient number
of cases; when this was not possible, we did not consider the
parameter because the evaluation could not be considered to be
reliable. The parameters were: (1) sex (male or female); (2) age
(.40 or #40); (3) location (frontal, central area, or temporo-
parietal); (4) lesion volume (#80 cm3 or .80 cm3); 5) lesion
margin (sharp or diffuse); 6) contrast enhancement (yes or no); 7)
cystic (yes or no); (8) MRI pattern of infiltration; (9) symptoms
(paresis, seizures, or other); (10) preoperative steroid administra-
tion (yes or no); (11) grading (WHO II or III or IV); (12)
preoperative RMS (equal to 0 or major of 0); (13) functional
Figure 1. These preoperative MRIs depict the five classes of subcortical infiltration pattern. (A) class 1: tumors invading and confined to
only 1 gyrus without infiltration of white matter connections; (B) class 2: tumors invading 1 gyrus with extension to white matter and/or adjacent
gyrus; (C) class 3: tumors infiltrating up to 3 gyri and extending toward the long range white matter tracts; (D) the same as class 3 but with a large
cystic component; (E) class 4: tumors primarily located in the white matter under eloquent gyri; (F) class 5: lobar tumors.
doi:10.1371/journal.pone.0080916.g001
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infiltrated cortex (yes or no); (14) positive subcortical stimulation.
x2 analyses were used to evaluate parameters that could be
predictive; the significance threshold was set at P,0.05; for
multiple comparison, we also computed what parameter survived
Bonferroni correction. We used three binary proxies to evaluate
positive/negative outcome: EOR total or subtotal; postoperative
RMS (worsened or equal/improved compared to Preoperative
RMS); and 6 month follow-up RMS (worsened or equal/
improved compared to Preoperative RMS).
We examined the relationships between outcome positive
indexes by comparing postoperative and follow-up RMS between
the EOR total and subtotal groups with a two sample paired t-test.
The multivariate logistic regression analyses were used to evaluate
the best combination to predict the binary positive outcomes.
Odds ratios with 95% confidence intervals were computed.
P,0.05 was considered significant. We tried all the different
combinations of significant factors using a minimum of 2 different
factors and a maximum of 5 different factors. Thus, we computed
112 different models for EOR (combination of 7 factors in models
of 2, 3, 4, and 5 factors), 1 model for postoperative RMS (2 factors)
and 56 models for follow-up RMS (combination of 7 factors in
models of 2, 3, 4, and 5 factors). We chose the models with the best
performance for predicting outcome; when models had similar
performance, we chose the more parsimonious.
Results
Table 1 summarizes demographics, clinical characteristics, and
MRI findings. Seizures were the most frequent symptom at
presentation, followed by motor impairment. The median tumor
volume was 59.6 (average: 78.2; range: 4.8–308.3 cm3). The class
3 pattern of extension (infiltration of up to 3 gyri plus extension to
long-range WM tracts) was the most common; however, the
tumors with a volume ,80 cm3 were predominant, compared to
larger tumors (36 vs. 24). Tumors with sharp margins and those
with less well-defined borders were approximately similarly
represented (52% vs. 48%, respectively). With the goal of reducing
neurological deficits, steroids were used in 19 patients (32%). In 17
patients, steroids reduced signs and symptoms. Half (50%) of the
patients had a preoperative RMS of 0 and none with a score of 4
was surgically treated (Table 2). Postoperatively, 51.6% of the
patients experienced a deterioration of their neurological status; 9
(15%) of these patients suffered aphasia, 18 (30%) suffered motor
impairment, and 4 (6.6%) suffered sensory disturbances and
apraxia. Among these, only 6 (10%) did not recover their motor
impairment to the preoperative status at the six-month follow-up;
all of these patients had HGGs (5 GBMs and 1 AA) and all had a
residue of tumor.
Surgical Findings and EOR
Mortality for the group was 0. There was no need for a
postoperative urgent craniotomy for intracranial bleeding. In just
one case (1.6%), a wound infection occurred, which resolved after
antibiotic administration. No cases were converted to general
anesthesia and no patients needed ICU monitoring. Intraopera-
tively, 6 patients (10%) had focal seizures that did not influence the
surgery; they were controlled with cold saline irrigation. Only two
of these patients suffered seizures preoperatively and just one
continued to experience seizures at the six-month follow-up.
Antiepileptic drug prophylaxis was not administered preopera-
tively to patients who had not experienced seizures. Globally,
86.6% of those who suffered seizures before surgery did not
experience seizures at follow-up.
In all patients, the presumed eloquent location of the tumors
was intraoperatively confirmed by detecting cortical and/or
subcortical responsive sites. Some tumors were separated from
functional gyri by a sulcus; however, in 54 (90%) it was possible to
elicit subcortical responses in the margins of the surgical cavity,
demonstrating the close proximity to the critical area. In 17
(45.9%) of these patients postoperative MRI showed residual
Table 1. Summary of the Demographic, Clinical, and
Neuroradiological Features of the Patients.
Age 48613 (range 72–19)
Sex M/F 21(35%)/39(65%)
Symptoms
seizures 30 (50%)
paresis 13 (22%)
dysesthesia 8 (13%)
aphasia 3 (5%)
none 6 (10%)
Handedness
Right 55 (91.6%)
Left 5 (8.3%)
Hemisphere
left 32 (53%)
right 28 (47%)
Site
Post-central 18 (30%)
Pre-central 12 (20%)
Frontal opercular 8 (13.3%)
SMA 6 (10%)
SMG - AG 7 (11.6%)
Middle frontal 3 (5%)
Posterior temporal 4 (6.6%)
Temporal opercular 2 (3.3%)
Median tumor volume cm3 59.6
,80 cm3 36 (53.3%)
.80 cm3 24 (46.7%)
Contrast enhancement
Yes 31 (52%)
No 29 (48%)
Cystic component
Yes 8 (13%)
No 52 (87%)
Pattern of extension
1- Single gyrus 4 (7%)
2- Single gyrus+WM 8 (13%)
3- Up to 3 gyri+long range WM tracts 29 (48%)
4- Exclusively in WM 1 3 (22%)
5- Lobar tumor 6(10%)
Type of margins
sharp 31 (52%)
diffuse 29 (48%)
SMA: supplementary motor area; SMG–AG: supramarginal gyrus-angular gyrus;
WM: white matter.
doi:10.1371/journal.pone.0080916.t001
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tumor exclusively located in the WM. The other residual tumors
(20 patients; 54%) had a cortico-subcortical location.
The EOR was total in 23 (38.3%) patients, subtotal in 32
(53.3%) and partial in 5 (8.3%). The mean residual tumor volume
in the subtotal resection group was 6.5 cm3 (range 1.5–13.3 cm3),
whereas in the partial resection group, it was 22.8 cm3 (range: 7.9–
37.2 cm3). As mentioned above, the residual tumors were
predominantly located in cortico-subcortical areas; they were less
frequently located in subcortical areas only. Table 3 shows the
postoperative MR findings.
Histologically, tumors showed malignant features WHO IV
malignant features in 17 patients (28%), whereas low grade
gliomas (WHO II) accounted for 18 patients (30%). There were 25
anaplastic tumors (42%).
Statistical Analysis and Prognostic Factors
Extent Of Resection (EOR). The predictive indices as
adverse outcome factors for EOR were tumor volume and the
pattern of infiltration on MRI with type 3 and 5 being the worst.
As mentioned above, it appears that volume plays a role; however,
in looking at mean volumes, it also appears that tumors not
exceeding certain volumes can infiltrate subcortical tracts and
restrict the amount of resection. Tumors that infiltrated the
functioning cortex (residual tumor located more cortically) were
also associated with unfavorable EOR. This condition is in direct
correlation with the presence of a preoperative motor deficit,
which is also a negative factor for EOR. Actually, the presence of
preoperative paresis can negatively influence EOR in two ways: it
is presumably the consequence of infiltration of delicate areas; and
the intraoperative worsening of a preexisting deficit can induce the
surgeon to prematurely arrest the resection. Steroids are almost
always effective in these more severe cases because they counteract
the effects of either compression or distortion; thus, their positive
effect cannot be reliably considered as proof of a less severe deficit.
Conversely, tumors with cystic components and well-defined
margins were easier to remove, and these indices were positive
outcome factors (Table 4).
Postoperative and 6-months Rankin Modified Scale
(RMS). For postoperative RMS, the only factor that survived
the Bonferroni test was the presence of paresis as a symptom that
predicted neurological deterioration (Table 4). Postoperative RMS
appeared to be a less reliable index because it does not differentiate
between total and subtotal resections (a well-known positive
prognostic factor); furthermore, it does not correlate as well
between the 6-month RMS (0.56; p,0.01) and the preoperative
RMS (0.73; p,0.01). A possible explanation is that the
postoperative RMS is probably also influenced by transitory
factors that diminish its prognostic value.
For follow-up Rankin, the malignant nature of the tumor
(WHO IV, without a clear margin and with contrast enhance-
ment) was a negative outcome factor (Table 4). Total resection
appears to also influence functional recovery because all the
deteriorated patients at 6 months underwent subtotal resections. In
addition, two independent sample t-tests using the total EOR as
grouping variable were significant for follow-up Rankin (Table 5).
The most practical explanation is that the presence of residual
high grade tumors in an eloquent location could negatively impact
clinical improvement either by becoming chronically inflamed or
by relapsing. Actually, all but one patient experienced a relapse of
their tumors at the six-months follow-up.
The best models for multivariate logistic regression are shown in
Table 6. For EOR, we obtained 87% correct predictions using
lesion margins, lesion volume, seizures, cystic lesions, MRI index 3
and 5. For Postoperative RMS we obtained 70% correct
predictions using lesion size and presence of preoperative paresis.
For follow-up Rankin we obtained 95% correct predictions using
histology, functional infiltrated cortex, and preoperative paresis.
Discussion
The focus of the present paper was to determine which factors
in EATs could be predictive of the EOR and functional outcome.
Traditionally, surgical series have analyzed outcomes based on the
anatomical location of the tumor (non-eloquent, near-eloquent, or
eloquent), with the eloquent location being an intrinsic negative
factor for the EOR and postoperative functional status
[20,22,24,25]. Intuitively, the prediction of both the EOR and
functional outcome is particularly hard to obtain even with the
help of modern neuroradiologic advancements such as fMRI and
Table 2. Overview of Preoperative and Postoperative Rankin
Modified Scores and KPS.
Preoperative Postoperative 6 months
RMS Nu
0 30 (50%) 16 (26.6%) 33 (55%)
1 24 (40%) 25 (41.6%) 19 (31.6%)
2 4 (6.6%) 7 (11.6%) 3 (5%)
3 2 (3.3%) 5 (8.3%) 2 (3.3%)
4 0 7 (11.6%) 3 (5%)
Mean RMS 0.660.8 1.461.3 0.761.1
KPS Preoperative Postoperative 6 months
100 30 (50%) 16 (26.6%) 33 (55%)
90 24 (40%) 25 (41.6%) 19 (31.6%)
80 4 (6.6%) 7 (11.6%) 3 (5%)
70 0 0 0
60 2 (3.3%) 5 (8.3%) 2 (3.3%)
50 0 3 (5%) 1 (1.6%)
40 0 4 (6.6%) 2 (3.3%)
Mean KPS 93.368.7 83.7618 91.6614.1
% of worsening 51.6% (31 pts) 10% (6 pts)
doi:10.1371/journal.pone.0080916.t002
Table 3. Extent of Resection as Evaluated on Postoperative
MRI with Volumetric Analysis and Location of Residual Tumor.
EOR
Total 23 (38.3%)
Subtotal 32 (53.3%)
Partial 5 (8.3%)
Volume of residue mean (cm3) range (cm3)
subtotal 6.5 1.5–13.3
partial 22.8 7.9–37.2
Residue site (37 pts)
Cortico-subcortical 20 (54%)
subcortical 17 (45.9%)
doi:10.1371/journal.pone.0080916.t003
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DTI-ft. As a consequence, the use of intraoperative brain mapping
has attracted a growing number of surgeons who operate on
patients with EATs because it results in improved outcomes.
Recently, Jakola et al. [26] postulated that, because eloquence can
modify the surgical strategy towards a less extensive resection, it
would be desirable to use all the possible methods to achieve a
larger resection.
We found that a relevant factor to be considered when
indicating this aggressive surgery appeared to be the grade of
malignancy. Actually, when an EAT presents with large contrast
enhancement, associated with some motor impairment, surgical
resection must be very carefully balanced with the risk of
insufficient resection and likely further deterioration due to the
progression of the residual tumor. It is known that restricted EOR
is associated with shorter PFS and OS and that in EATs this
condition can also lead to a poor functional outcome and to an
eventual worsening of the global prognosis by reducing the
possibility to administer adjuvant therapies [27,32]. In fact, the
strategy to achieve a subtotal resection can be better envisioned in
a slow-growing tumor where the plastic potential of the brain
allows for a repeat procedure on the patient years later that can
obtain a larger resection [28]. In the current series total resection
was found to be strongly associated with the maintenance of good
neurological performance. Although all the tumors were located in
critical areas, as intraoperatively confirmed by a positive
subcortical stimulation in 90% of cases, partial resection (PR)
accounted for only 8.3% of the cases with the rest being total and
subtotal resections. This result is important in supporting the
concept that intraoperative mapping also allows more aggressive
resections of tumors within eloquent areas. Globally, our
functional outcomes were satisfactory, with 90% of patients
returning to their baseline RMS. Nevertheless, other recent series
of patients operated on through awake surgery and CSES for
EATs have reported better definitive functional outcomes [29,30].
This discrepancy is likely due to the fact that those series were
based on LGGs, whereas our series dealt with a higher percentage
of HGGs. This hypothesis is also supported by the fact that, as
reported in our results, seizures as presenting symptoms showed a
positive effect on both the EOR and functional outcome as they
typically are associated with LGGs.
Table 4. Outcome Based on Clinical, Demographic, and MRI Variables.
Variable EOR x2 Post-SurgeryRankin x2 Follow-up Rankin x2
Sex – 0.38 – 0.55 – 0.35
Age – 0.33 – 0.41 – 0.63
Localization – 0.26 – 0.33 – 0.95
Sharp margins POS ,0.01 0.10 POS ,0.01
Volume neg ,0.01 – 0.17 – 0.29
C. E. – 0.20 – 0.09 neg 0.02
Cystic POS ,0.01 – 0.56 – 0.41
MRI index .2 neg ,0.01 – 0.55 – 0.82
Symptoms Paresis neg/Seizure POS ,0.01 Paresis neg/Seizure POS ,0.01 Paresis neg/Seizure POS ,0.01
Steroid – 0.06 – 0.07 – 0.28
WHO – 0.12 – 0.21 IV neg ,0.01
Preoperative RMS neg 0.02 – 0.30 – 0.10
FI- cort neg ,0.01 – 0.42 neg 0.02
SC-pos-STIM – 0.06 – 0.08 – 0.42
Outcome POS/NEG= x2 (significant: P,0.05); POS = positive outcome factor, NEG=negative outcome factor.
P in bold: significant P,0.05; Bonferroni corrected for multiple comparison.
FI: infiltrated functional cortex.
doi:10.1371/journal.pone.0080916.t004
Table 5. Comparison of Outcome Variables.
Variables EOR subtotal EOR total p
Postoperative RMS 20.961.1 20.561.0 0.23
6-months RMS 20.260.8 0.260.4 0.03
P in bold: significant (P,0.05).
doi:10.1371/journal.pone.0080916.t005
Table 6. Multivariate logistic regression for EOR,
Postoperative RMS, and Follow-Up RMS.
EOR
Variables B s.e. OR 95% CI p
Sharp margins 21.95 0.95 0.142 0.022–0.913 0.04
Cystic 24.71 1.58 0.009 0.000–0.202 ,0.01
MRI index 3,4,5 1.89 0.91 6.615 1.108–39.481 0.04
Seizure 22.70 1.05 0.067 0.009–0.521 ,0.01
Volume 1.89 1.03 6.646 0.885–49.923 0.06
Postoperative RMS
Paresis 1.87 0.76 6.466 1.468–28.483 0.01
Follow-up RMS
WHO IV 2.147 1.464 8.559 0.486–150.773 0.14
FI-cort 3.027 1.455 20.635 1.192–357.269 0.04
Paresis 3.146 1.501 23.237 1.227–440.239 0.04
B = logistic regression beta; s.e. = standard error; OR = odds ratio;
CI = confidence interval.
doi:10.1371/journal.pone.0080916.t006
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Although we are currently adopting increased usage of surgical
mapping techniques, concepts and results reported in other larger
series differ; thus, their conclusions can be misleading. In a recent
paper by De Witt Hamer et al. [31], the authors searched the
literature for patients operated on for supratentorial gliomas with
and without direct mapping. They found that those patients
operated through CSES had fewer late severe neurologic deficits
and more extensive resection, despite the fact that their tumors
were located more frequently in eloquent locations. Conversely,
other authors reported that the EOR significantly decreases with
the size of the tumor and/or its location at or near eloquent areas
[25,32]. Moreover, Keles et al. found that patients in whom CSES
identified subcortical pathways were more prone to develop
permanent or temporary postoperative deficits [14]. Kim et al.
[22] reported that the intraoperative detection of eloquent areas is
a strong predictor of poor functional outcome; therefore, they
stated that negative mapping can assure a safer resection. These
latter authors did not use subcortical stimulation; therefore, in
those cases where cortical eloquent epicenters were detected, they
could have lost the opportunity to verify subcortical functional
connectivity and potentially avoid damage. This mechanism could
explain why, in their experience, patients who underwent positive
cortical stimulation were found to have a higher percentage of
deterioration. However, in our opinion, the absence of intraop-
erative cortical or subcortical responsive sites could mean that
some of these tumors were actually not classifiable as EATs.
Interestingly, we did not detect any statistically significant
difference in EOR and functional outcomes between locations. We
must admit that, in this series, some locations were not represented
(i.e., insular tumors and basal ganglia tumors) because of the
different technical problems related to complex anatomical
features and different outcomes. Similarly, the detection of
subcortical functional pathways did not result in a negative
prognostic factor ‘‘per se’’, neither in the postoperative period nor
at follow-up. As expected, a large portion of the patients operated
through CSES experienced neurological deterioration postopera-
tively as a function of the manipulation of delicate structures;
furthermore, none of the preoperative factors but paresis could
predict postoperative deterioration. To confirm this, compared to
the predictive power of postoperative worsening alone, paresis was
also a stronger predictor of poor 6-months follow-up as well.
Interestingly, paresis also affects EOR via the aforementioned
hypothesized mechanisms hypo.
As reported in recent series [21–26], volume is a predictor of
restricted resection; however, we found that some other aspects
were also involved. In fact, in attempting to determine the role of
tumor morphology and the relationship between tumor and brain,
we adopted a practical MRI classification that accounted for the
degree of diffusion of the tumor to the subcortical connection.
Those tumors extending toward subcortical tracts (namely class 3
and 5) were less amenable to gross total resection and this situation
was not significantly related to the volume. In regard to those
points, Castellano et al. [33] demonstrated that the presence of
infiltrated or displaced fascicles on preoperative DTI-ft was
predictive of a lower probability of total resection, especially for
tumors with a smaller preoperative volume in which an extensive
removal could be foreseen. However, we noted that morpho-
structural factors related to the biology of the tumor were also
involved in determining the EOR. The tumor-brain interface
seemed to influence the resection by creating better dissection’s
planes, both for non-enhancing and enhancing tumors. Similarly,
Talos et al. [34] found that a large tumor volume was associated
with a diffuse tumor margin, and oligodendroglioma or oligoas-
trocytoma histopathologic types were predictors of incomplete
resection. They also stated that tumor involvement of some
structures such as the cortico-spinal tract is always predictive of
reduced resection. Mandonnet et al. [35], proposed a probabilistic
map for the prediction of resectability of LGGs based on the
residual tumor present on a postoperative MRI. Interestingly, they
found that the areas with the highest probability to have residual
tumor were located subcortically. In fact, they attributed this result
not only to the wide cortical functional variability but also to the
remapping of brain function induced by the tumor [36].
Although the current study is limited by its retrospective design
and by a limited number of patients, we hypothesize that, in the
future, probabilistic maps of the prediction of EOR will also take
into account (in accordance with our results) other clinical and
morphological factors related to tumor growth rate and biological
behavior.
Conclusions
Gliomas in eloquent areas are challenging tumors that require
extensive knowledge of their natural history, anatomic character-
istics, and interactions with brain. Technical skills are mandatory
but conceptual implications are essential as well. The surgeon
must evaluate all the possible clinical, radiological and surgical
peculiarities of each individual single patient in order to compose
his own experience in predicting risks and benefits. This work
cannot solve all the matters regarding EATs; however, it may add
additional information regarding the appropriate selection of
patients to obtain the best surgical and functional results.
Specifically, we obtained 88% correct predictions for the EOR
using margin morphology, tumor volume, symptoms, cystic
components, and the degree of infiltration of the white matter.
For follow-up Rankin, we obtained 95% correct predictions using
histology, infiltrated functional cortex, and preoperative paresis.
We propose that in the future, because of neuroradiologic
advancements, it will be possible to better predict the EOR and
outcome. In addition, we foresee that these parameters could be of
interest for empowering the decisional pathway.
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